Association between RUNX3 promoter methylation and gastric cancer: a meta-analysis
2011

RUNX3 Methylation and Gastric Cancer

Sample size: 1740 publication Evidence: high

Author Information

Author(s): Fan Xiao-yuan, Hu Xin-lei, Han Tie-mei, Wang Na-na, Zhu Yi-miao, Hu Wen, Ma Zhen-hua, Zhang Chen-jing, Xu Xiang, Ye Zai-yuan, Han Chun-mao, Pan Wen-sheng

Primary Institution: Second Affiliated Hospital, Zhejiang University, School of Medicine

Hypothesis

Is there an association between RUNX3 promoter methylation and gastric cancer?

Conclusion

The study found a strong association between RUNX3 promoter methylation and gastric cancer, supporting its role as a tumor suppressor gene.

Supporting Evidence

  • The pooled odds ratio for RUNX3 methylation in cancer tissues compared to normal tissues was 5.63.
  • Younger individuals had higher RUNX3 methylation rates than older individuals.
  • RUNX3 methylation was more frequent in intestinal-type gastric carcinomas compared to diffuse-type.

Takeaway

This study shows that a specific change in a gene called RUNX3 is linked to stomach cancer, which means it might help us understand how this cancer develops.

Methodology

The study systematically reviewed and analyzed data from 17 studies on RUNX3 promoter methylation in gastric cancer using meta-analysis methods.

Potential Biases

There was a risk of bias due to smaller studies reporting more positive associations.

Limitations

The study faced heterogeneity among included studies and potential publication bias.

Participant Demographics

The analysis included 974 participants from various studies, with a mix of ethnic backgrounds.

Statistical Information

P-Value

<0.0001

Confidence Interval

95%CI 3.15, 10.07

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1471-230X-11-92

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication